Search review questions

Recovery not achieved according to Morgan and Russell narrow categories or similar ‐ IPT versus SSCM at end of treatment periods · Adults and older adolescents with anorexia nervosa

Weight · Adults and older adolescents with anorexia nervosa

Weight · Adults and older adolescents with anorexia nervosa

Recovery not achieved according to Morgan and Russell narrow categories or similar ‐ CBT versus IPT or FPDT at end of treatment periods · Adults and older adolescents with anorexia nervosa

Recovery not achieved according to Morgan and Russell narrow categories or similar ‐ Cognitive orientation therapy (COT) versus self psychology (SP) both with nutritional counselling) at end of treatment periods · Adults and older adolescents with anorexia nervosa

Recovery not achieved according to Morgan and Russell narrow categories or similar at end of 1 year FPT treatment ‐ FPT versus TAU · Adults and older adolescents with anorexia nervosa

Recovery not achieved according to Morgan and Russell narrow categories or similar at end of 1 year · Adults and older adolescents with anorexia nervosa

Weight · Adults and older adolescents with anorexia nervosa

Weight · Adults and older adolescents with anorexia nervosa

Weight · Adults and older adolescents with anorexia nervosa

Weight · Adults and older adolescents with anorexia nervosa

Weight · Adults and older adolescents with anorexia nervosa

Recovery according to Morgan and Russell narrow categories or similar ‐ CBT versus SSCM (Global outcome rated 3 or 4) at end of treatment periods · Adults and older adolescents with anorexia nervosa

Remission of anxiety diagnoses (ITT analysis) i.e. no longer meeting criteria for DSM or ICD anxiety diagnosis at the end of the trial. · children and adolescents with anxiety disorders

Participants lost to · children and adolescents with anxiety disorders

Reduction in anxiety symptoms at the end of the trial · children and adolescents with anxiety disorders

Remission of anxiety diagnoses: long‐term · children and adolescents with anxiety disorders

Reduction in anxiety symptoms: long‐term · children and adolescents with anxiety disorders

Remission of anxiety diagnoses (ITT) analysis i.e. no longer meeting criteria for DSM or ICD anxiety diagnosis at the end of the trial. · children and adolescents with anxiety disorders

Reduction in anxiety symptoms at the end of the trial · children and adolescents with anxiety disorders

Remission of anxiety diagnoses (ITT analysis) i.e. no longer meeting criteria for DSM or ICD anxiety diagnosis at the end of the trial. · children and adolescents with anxiety disorders

Reduction of anxiety symptoms at the end of the trial · children and adolescents with anxiety disorders

Prevalence of psychological trauma (short term: up to 3 months postpartum) Measured by various scales ‐ Impact of Event Scale (IES), MINI‐PTSD · Women of any age who had given birth within one month of the intervention being offered

Prevalence of depression or depressive symptoms (short term: up to 3 months postpartum) Measured by various scales ‐ EPDS, HADS · Women of any age who had given birth within one month of the intervention being offered

Prevalence of anxiety (short term: up to 3 months postpartum) Measured by HADS · Women of any age who had given birth within one month of the intervention being offered

Prevalence of fear of childbirth (short term: up to 3 months postpartum) · Women of any age who had given birth within one month of the intervention being offered

Prevalence of general psychological morbidity (short term: up to 3 months postpartum) · Women of any age who had given birth within one month of the intervention being offered

Health service utilization (short term: up to 3 months postpartum) · Women of any age who had given birth within one month of the intervention being offered

Attrition from treatment (short term: up to 3 months postpartum) · Women of any age who had given birth within one month of the intervention being offered

Treatment responseCGI‐I · people with anxiety and comorbid alcohol use disorders

Symptom severity reductionLSAS · people with anxiety and comorbid alcohol use disorders

Treatment acceptability · people with anxiety and comorbid alcohol use disorders

Proportion heavy drinking days · people with anxiety and comorbid alcohol use disorders

Proportion of days abstinent · people with anxiety and comorbid alcohol use disorders

Drinks per drinking day · people with anxiety and comorbid alcohol use disorders

Depression symptom reduction · people with anxiety and comorbid alcohol use disorders

Treatment efficacy: treatment responders As assessed per study · Adults with anxiety disorders

In remission As assessed per study · Children and adolescents with anxiety disorders

Condition‐specific anxiety symptoms As assessed by Y‐BOCS3 (scale from 0 to 40, better indicated by a lower score) · Children and adolescents with anxiety disorders

Co‐morbid symptoms of depression As assessed by CDI5 (scale from 0 to 54, better indicated by a lower score) · Children and adolescents with anxiety disorders

Co‐morbid anxiety symptoms As assessed by each study · Children and adolescents with anxiety disorders

Quality of life · Children and adolescents with anxiety disorders

Treatment acceptability: withdrawals from treatment · Adults with anxiety disorders

In remission As assessed per study · Adults with anxiety disorders

Condition‐specific anxiety symptoms As assessed by LSAS5 (scale from: 0 to 144, better indicated by a lower score. 55 to 65 points = moderate social anxiety disorder (Liebowitz 1987)) · Adults with anxiety disorders

Co‐morbid symptoms of depression As assessed by BDI‐II7 (scale from: 0 to 63, better indicated by a lower score) · Adults with anxiety disorders

Co‐morbid anxiety symptoms As assessed by BAI9 (scale from: 0 to 63, better indicated by a lower score. 8 to 15 points = mild anxiety, 16 to 25 points = moderate anxiety (Beck 1993)) · Adults with anxiety disorders

Quality of life Assessed by LIS (scale from: 0 to 48, better indicated by a lower score) · Adults with anxiety disorders

Treatment efficacy: treatment responders As assessed per study · Children and adolescents with anxiety disorders

Treatment acceptability: withdrawals from treatment · Children and adolescents with anxiety disorders